(19)
(11) EP 4 824 086 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24829096.7

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07K 16/10(2026.01)
A61P 31/16(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/505; A61K 2039/507; A61P 31/16; C07K 2317/22; C07K 2317/24; C07K 2317/31; C07K 2317/33; C07K 2317/34; C07K 2317/52; C07K 2317/569; C07K 2317/62; C07K 2317/64; C07K 2317/732; C07K 2317/76; C07K 2319/00; C07K 16/108
(86) International application number:
PCT/EP2024/086236
(87) International publication number:
WO 2025/125577 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 EP 23216759
12.09.2024 EP 24199972

(71) Applicants:
  • VIB VZW
    9052 Gent (BE)
  • Universiteit Gent
    9000 Gent (BE)

(72) Inventors:
  • SAELENS, Xavier
    9052 Gent (BE)
  • MATTHYS, Arne
    9052 Gent (BE)
  • SAVVIDES, Savvas
    9052 Gent (BE)
  • FELIX, Jan
    9052 Gent (BE)

   


(54) ANTIBODIES AGAINST INFLUENZA B VIRUS